Synthetic production of potential pharmaceuticals dramatically simplified by Scripps research team

March 21, 2007

Chemists are currently able to synthetically produce almost any compound, but they must typically resort to expensive, complex processes that can require dozens of individual steps. Such natural product syntheses have traditionally relied on the ubiquitous use of "protecting groups," which are extra compounds chemists use to shield reactive portions of a molecule during specific stages of a synthesis scheme. The protecting groups are eventually cleaved chemically to expose the reactive portion during later chemical reactions to complete a product's synthesis. Each protecting group used adds at least two steps to a synthesis, and the groups themselves have reactivity of their own that must be controlled to prevent adverse reactions.

"Protecting groups are almost always a direct result of an inability to address selectivity in synthesis," says project leader Phil Baran, a chemist with The Scripps Research Institute. "It is ironic that they often add an additional layer of problems on top of the preexisting ones."

Organic chemistry textbooks have long declared that the use of protecting groups was essential in natural product synthesis. "Textbooks have pointed out that avoiding protecting groups is like 'avoiding death and taxes,'" says Baran, who, along with Scripps Research Kellogg School of Science and Technology graduate students Thomas Maimone and Jeremy Richter, has now disproved the belief.

To avoid the need for protecting groups, the Baran group took an unorthodox approach. Rather than assume that reactive portions of a molecule had to be shielded during various syntheses, the researchers calculated ways to use such reactivity in an overall scheme to produce the desired final product. Baran says the reason such an approach had not been successfully developed before was likely a by-product of education. "From the beginning, we were always taught that the way to solve these types of problems is to protect functionality rather than to try to embrace it," he says.

In the Nature paper, the group showed that, without using a single protecting group, they could produce the representative members of a whole family of over 60 different marine natural products produced by the Stigonemataceae family of cyanobacteria. This family of products has a wide range of bioactivities including anticancer and antibacterial, and some may eventually be developed as commercial pharmaceutical products. The compound family was only used as an example, however, as the demonstrated concepts and principles should be applicable to the synthesis of a wide range of marine and terrestrial natural products.

To synthesize the products, the team designed a variety of chemical reactions that maximize the bonding of carbon atoms between different molecules. In many cases, the products were synthesized in gram quantities in less than 10 steps, as compared to traditional syntheses using protecting groups that have taken as many as 30 steps to produce milligrams of product.

Use of the techniques the group has developed could therefore lead to substantially reduced production costs for natural products. This is a critical concern, as identification of a reasonably economic means of production for marine and other natural products is typically one of the most challenging hurdles in a potential drug's commercial development. An overly complex and expensive synthesis can even slow or halt the development of an otherwise promising drug candidate.

Beyond economic ramifications, Baran hopes the research will offer additional benefits to the drug discovery field. Many pharmaceutical companies' potential drug pipelines are drying up, leading some to suggest that interest in natural products should be renewed. A range of drugs from aspirin to the widely used cancer treatment Taxol has been discovered in nature, but the complexity of producing natural products has made some companies reluctant to focus on them.

"There is this far-ranging and damaging perception that natural products are too complex to be used in a drug discovery setting despite their overwhelming track record in medicine," says Baran. "I think if our work has helped in even a small way to revive the use of natural products, then we've served our purpose."

The Baran team has focused its work to date on marine natural products, because these chemical compounds from sponges, algae, and other organisms have proven a rich source of bioactivity with pharmaceutical potential, but have also been challenging to work with. Marine natural products are ideal targets for simplified synthesis techniques because they tend to be exceptionally complex, and because they are typically difficult to collect. Researchers often struggle to amass marine organism samples in quantities great enough to yield the volume of a given compound needed for research and clinical trials, much less commercial production, making better and cheaper production means all the more critical.

For the production of some products, both natural and man-made, the use of protecting groups will still be the most efficient route, says Baran. "We are not advocating that one should blindly throw away the protecting groups book just for the fun of throwing it away," he says. "It's something that should be strategically applied."
-end-
Baran, Maimone, and Richter were all authors on the study, "Total Synthesis of Marine Natural Products Without Using Protecting Groups."

This work was supported by The Scripps Research Institute, Amgen, AstraZeneca, the Beckman Foundation, Bristol-Myers Squibb, DuPont, Eli Lilly, GlaxoSmithKline, Pfizer, Roche, the Searle Scholarship Fund, the Sloan Foundation, the National Science Foundation, and the National Institutes of Health.

The research is being published on March 22, 2007 in the journal Nature.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.

Scripps Research Institute

Related Chemical Reactions Articles from Brightsurf:

Shedding light on how urban grime affects chemical reactions in cities
Many city surfaces are coated with a layer of soot, pollutants, metals, organic compounds and other molecules known as ''urban grime.'' Chemical reactions that occur in this complex milieu can affect air and water quality.

Seeing chemical reactions with music
Audible sound enables chemical coloring and the coexistence of different chemical reactions in a solution.

Nanocatalysts that remotely control chemical reactions inside living cells
POSTECH professor In Su Lee's research team develops a magnetic field-induced heating 'hollow nanoreactors'.

New NMR method enables monitoring of chemical reactions in metal containers
Scientists have developed a new method of observing chemical reactions in metal containers.

Levitating droplets allow scientists to perform 'touchless' chemical reactions
Levitation has long been a staple of magic tricks and movies.

Predicting unpredictable reactions
New research from the University of Pittsburgh's Swanson School of Engineering, in collaboration with the Laboratory of Catalysis and Catalytic Processes (Department of Energy) at Politecnico di Milano in Milan, Italy, advances the field of computational catalysis by paving the way for the simulation of realistic catalysts under reaction conditions.

First-time direct proof of chemical reactions in particulates
Researchers at the Paul Scherrer Institute PSI have developed a new method to analyse particulate matter more precisely than ever before.

Finding the source of chemical reactions
In a collaborative project with MIT and other universities, scientists at Argonne National Laboratory have experimentally detected the fleeting transition state that occurs at the origin of a chemical reaction.

Accelerating chemical reactions without direct contact with a catalyst
Northwestern University researchers demonstrate a chemical reaction produced through an intermediary created by a separate chemical reaction, findings that could impact environmental remediation and fuel production.

Visualizing chemical reactions, e.g. from H2 and CO2 to synthetic natural gas
Scientists at EPFL have designed a reactor that can use IR thermography to visualize dynamic surface reactions and correlate it with other rapid gas analysis methods to obtain a holistic understanding of the reaction in rapidly changing conditions.

Read More: Chemical Reactions News and Chemical Reactions Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.